+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Molecular Oncology Diagnostics Market by Product Type (Instruments, Reagents & Kits, Software & Services), Technology (Fluorescence In Situ Hybridization, Immunohistochemistry, Microarray), Test Type, Application, Cancer Type, End User, Sample Type - Global Forecast 2025-2030- Product Image
Molecular Oncology Diagnostics Market by Product Type (Instruments, Reagents & Kits, Software & Services), Technology (Fluorescence In Situ Hybridization, Immunohistochemistry, Microarray), Test Type, Application, Cancer Type, End User, Sample Type - Global Forecast 2025-2030- Product Image
Sale

Molecular Oncology Diagnostics Market by Product Type (Instruments, Reagents & Kits, Software & Services), Technology (Fluorescence In Situ Hybridization, Immunohistochemistry, Microarray), Test Type, Application, Cancer Type, End User, Sample Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925194
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Molecular oncology diagnostics is rapidly advancing as a cornerstone technology in precision cancer care, leveraging genomic innovations and integrated bioinformatics to deliver tailored, patient-centric solutions. Senior leaders shaping strategic vision or investment portfolios in healthcare and biotechnology must now navigate a dynamic and evolving diagnostics landscape—one balancing robust innovation with operational and regulatory demands.

Market Snapshot: Molecular Oncology Diagnostics Market

The global molecular oncology diagnostics market grew from USD 9.88 billion in 2024 to USD 11.10 billion in 2025 and is forecast to reach USD 19.38 billion by 2030, exhibiting a CAGR of 11.87% over the forecast period. This sustained growth reflects expanding adoption of advanced diagnostics across health systems aiming to improve oncology outcomes and resource allocation. Market expansion is underpinned by rising cancer prevalence, impactful regulatory changes, and a robust innovation pipeline.

Scope & Segmentation

  • Product Types: Instruments, reagents and kits, as well as software and services represent the core offerings supporting laboratory workflows.
  • Technologies: The market encompasses fluorescence in situ hybridization, immunohistochemistry, microarray, next-generation sequencing (including targeted sequencing, comprehensive and hotspot panels, whole exome, whole genome), and real-time PCR.
  • Test Types: Liquid biopsy, multi-gene and single-gene panel testing, along with whole exome and genome sequencing, enable a spectrum of monitoring and diagnostic applications.
  • Applications: Companion diagnostics, early detection, personalized medicine, prognosis and monitoring, and research-oriented assays drive adoption across the oncology cycle.
  • Cancer Types: Focus areas include breast, colorectal, leukemia, lung, and prostate malignancies.
  • End Users: The principal stakeholders are diagnostic laboratories, hospitals and clinics, pharmaceutical and biotech companies, and research institutes.
  • Sample Types: Assays utilize plasma-based, saliva and urine-based, tissue-based, and whole blood samples to maximize diagnostic flexibility.
  • Geographic Coverage: Americas (United States with key states, Canada, Mexico, Brazil, Argentina), Europe Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, among others), and Asia-Pacific (China, India, Japan, Australia, South Korea, and several others).
  • Company Coverage: Major contributors include F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Illumina Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Danaher Corporation, Hologic, Inc., Exact Sciences Corporation, and Guardant Health, Inc.

Key Takeaways for Decision Makers

  • Recent breakthroughs in next-generation sequencing, digital droplet PCR, and automated bioinformatics are raising assay accuracy and speed, enabling earlier intervention and personalized therapeutic strategies.
  • Collaborative models, linking diagnostic labs with pharmaceutical developers, are driving the development of companion diagnostics and accelerating clinical adoption of targeted therapies.
  • Adoption of liquid biopsy and non-invasive sample types is enhancing patient experience and supporting frequent monitoring, crucial for both research and clinical care.
  • Digital pathology and AI-driven analytics are becoming pivotal in interpreting complex molecular datasets, allowing integration of morphological and molecular information for precise diagnoses.
  • Regional market trends are shaped by disparities in healthcare infrastructure, investment levels, and evolving reimbursement policies, which influence technology uptake and access to precision diagnostics.

Tariff Impact on the Molecular Oncology Diagnostics Landscape

The introduction of United States tariffs on imported laboratory reagents, sequencing consumables, and specialized instrumentation in 2025 prompted a strategic reevaluation of supply chains. These policies increased operational complexity, extended procurement timelines, and pressured margins—particularly impacting smaller enterprises with reduced economies of scale. In response, stakeholders have diversified supplier networks, invested in regional manufacturing partnerships, and pursued process automation to enhance resilience and control costs.

Methodology & Data Sources

Research for this report integrated qualitative interviews with industry experts and quantitative data from regulatory filings, clinical trial registries, scientific literature, and company disclosures. Thorough triangulation ensured the accuracy, relevance, and consistency of all insights presented.

Why This Report Matters

  • Delivers evidence-based intelligence to inform investment strategies, operational planning, and R&D prioritization in molecular oncology diagnostics.
  • Supports executive decision making through clear segmentation, technology analysis, and actionable recommendations attuned to both global and region-specific dynamics.

Conclusion

Molecular oncology diagnostics is reshaping cancer care and offering tangible opportunities for technology leaders and investors. Executives who take proactive, evidence-driven steps will position their organizations at the forefront of value-based precision diagnostics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven bioinformatics platforms for complex tumor profiling and targeted therapy selection
5.2. Emergence of CRISPR-based liquid biopsy diagnostics for real-time monitoring of minimal residual disease in oncology
5.3. Expansion of multi-omics assays integrating genomics, transcriptomics, and proteomics for personalized oncology diagnosis
5.4. Rising adoption of next-generation sequencing panels targeting actionable cancer biomarkers in clinical practice
5.5. Development of digital pathology and AI-powered image analysis tools for more accurate molecular oncology diagnostics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Molecular Oncology Diagnostics Market, by Product Type
8.1. Introduction
8.2. Instruments
8.3. Reagents & Kits
8.4. Software & Services
9. Molecular Oncology Diagnostics Market, by Technology
9.1. Introduction
9.2. Fluorescence In Situ Hybridization
9.3. Immunohistochemistry
9.4. Microarray
9.5. Next Generation Sequencing
9.5.1. Targeted Sequencing
9.5.1.1. Comprehensive Panel
9.5.1.2. Hotspot Panel
9.5.2. Whole Exome Sequencing
9.5.3. Whole Genome Sequencing
9.6. Real Time PCR
10. Molecular Oncology Diagnostics Market, by Test Type
10.1. Introduction
10.2. Liquid Biopsy
10.3. Multi Gene Panel Testing
10.4. Single Gene Testing
10.5. Whole Exome Sequencing
10.6. Whole Genome Sequencing
11. Molecular Oncology Diagnostics Market, by Application
11.1. Introduction
11.2. Companion Diagnostics
11.3. Early Detection
11.4. Personalized Medicine
11.5. Prognosis & Monitoring
11.6. Research Use
12. Molecular Oncology Diagnostics Market, by Cancer Type
12.1. Introduction
12.2. Breast Cancer
12.3. Colorectal Cancer
12.4. Leukemia
12.5. Lung Cancer
12.6. Prostate Cancer
13. Molecular Oncology Diagnostics Market, by End User
13.1. Introduction
13.2. Diagnostic Laboratories
13.3. Hospitals & Clinics
13.4. Pharmaceutical & Biotech Companies
13.5. Research Institutes
14. Molecular Oncology Diagnostics Market, by Sample Type
14.1. Introduction
14.2. Plasma Based
14.3. Saliva & Urine
14.4. Tissue Based
14.5. Whole Blood
15. Americas Molecular Oncology Diagnostics Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Molecular Oncology Diagnostics Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Molecular Oncology Diagnostics Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. F. Hoffmann-La Roche Ltd
18.3.2. Thermo Fisher Scientific Inc.
18.3.3. Illumina Inc.
18.3.4. QIAGEN N.V.
18.3.5. Bio-Rad Laboratories, Inc.
18.3.6. Agilent Technologies, Inc.
18.3.7. Danaher Corporation
18.3.8. Hologic, Inc.
18.3.9. Exact Sciences Corporation
18.3.10. Guardant Health, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. MOLECULAR ONCOLOGY DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. MOLECULAR ONCOLOGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. MOLECULAR ONCOLOGY DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 30. MOLECULAR ONCOLOGY DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 31. MOLECULAR ONCOLOGY DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 32. MOLECULAR ONCOLOGY DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COMPREHENSIVE PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COMPREHENSIVE PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY HOTSPOT PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY HOTSPOT PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY MULTI GENE PANEL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY MULTI GENE PANEL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SINGLE GENE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SINGLE GENE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY EARLY DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PROGNOSIS & MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PROGNOSIS & MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY RESEARCH USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY RESEARCH USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PLASMA BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PLASMA BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SALIVA & URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SALIVA & URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TISSUE BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TISSUE BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 139. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 144. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 145. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
TABLE 146. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2030 (USD MILLION)
TABLE 147. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 162. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 163. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
TABLE 164. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2030 (USD MILLION)
TABLE 165. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 249. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 254. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 255. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
TABLE 256. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2030 (USD MILLION)
TABLE 257. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 258. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 259. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 262. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 263. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 266. GERMANY MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 267. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 272. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 273. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
TABLE 274. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2030 (USD MILLION)
TABLE 275. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 276. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 277. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 280. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 281. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 284. FRANCE MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA MOLECULAR ONCOLOGY DIAGNOSTICS MARKET SIZE, BY EN

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Molecular Oncology Diagnostics market report include:
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Hologic, Inc.
  • Exact Sciences Corporation
  • Guardant Health, Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 19.38 Billion
Compound Annual Growth Rate11.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Molecular Diagnostics Market by Offering (Instruments, Reagents & Kits, Software & Services), Technology (Fluorescence In Situ Hybridization, Mass Spectrometry, Microarray Analysis), Specimen Type, Test Type, Application, End User - Global Forecast 2025-2030 - Product Image

Molecular Diagnostics Market by Offering (Instruments, Reagents & Kits, Software & Services), Technology (Fluorescence In Situ Hybridization, Mass Spectrometry, Microarray Analysis), Specimen Type, Test Type, Application, End User - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Colorectal Cancer Molecular Diagnostics Market by Technology (Fluorescence in Situ Hybridization, Microarray, Next Generation Sequencing), Product Type (Instruments, Kits Reagents, Software Services), Application, Biomarker, Sample Type, End User - Global Forecast 2025-2030 - Product Image

Colorectal Cancer Molecular Diagnostics Market by Technology (Fluorescence in Situ Hybridization, Microarray, Next Generation Sequencing), Product Type (Instruments, Kits Reagents, Software Services), Application, Biomarker, Sample Type, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Molecular Oncology Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Molecular Oncology Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Molecular Oncology Diagnostics Market - A Global and Regional Analysis: Focus on Product, Technology, Application, Cancer Type, End User, and Country - Analysis and Forecast, 2024-2033 - Product Image

Molecular Oncology Diagnostics Market - A Global and Regional Analysis: Focus on Product, Technology, Application, Cancer Type, End User, and Country - Analysis and Forecast, 2024-2033

  • Report
  • 171 Pages
  • Global
From
Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis - Product Image

Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis

  • Report
  • 472 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.